Clinical Trial 43493

New York, NY 10022


Study 43493 Flyer
Click image to enlarge

A phase 3 clinical research study is being conducted for moderate to severe eczema. An investigational drug or placebo will be given to qualified participants to evaluate the safety and effectiveness of an investigational drug in the treatment of moderate to severe eczema.

Qualified Participants Must:

• Be at least 18 years old
• Have had chronic atopic dermatitis for at least 2 years
• Have documented inadequate response to topical medications for treatment of Atopic Dermatitis

Qualified Participants May Receive:

Participants will receive all study-related care and study drug at no cost. Reimbursement for time and travel related to study may be available as well.

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.